Back to search

Netherlands· NL-a5d6ead61a44

Salagen 5 mg, filmomhulde tabletten

A pilocarpine product containing pilocarpinehydrochloride, registered in Netherlands by Euro Registratie Collectief B.V.. The same ATC class is registered in 9 of our 19 countries.

ATC N07AX01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSalagen 5 mg, filmomhulde tablettenATCN07AX01REGISTER NO.NL-a5d6ead61a44PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Pilocarpine is registered in 9 of 19 countries.

Countries holding a registration under ATC N07AX01 (pilocarpine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 4 of them publish a price we can compare per daily dose

Pilocarpine · ATC N07AX01

9 / 19 countries

  • Canada
  • Finlandprice
  • Germany
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pilocarpine costs, country by country.

Normalised to the WHO defined daily dose (15 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Pilocarpine · price per daily dose (15 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.26
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
PILOCARPINEHYDROCHLORIDE
Manufacturer
Euro Registratie Collectief B.V.
Country
Netherlands (NL)
ATC code
N07AX01
ATC class
Pilocarpine
Defined daily dose
15 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    123101//21111

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

139 interactions on record for pilocarpine.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Pilocarpine · interactions on record

139 records

  • 2 severe
  • 34 moderate
  • 103 info

Most severe, free to view

  • SiponimodL04AA42severe
  • SiponimodL04AE03severe
  • DicycloverineA03AA07moderate
  • PropanthelineA03AB05moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pilocarpine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pilocarpine products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Pilocarpin Agepha, Pilocarpin Puroptal
  • Belgium · Isopto
  • Bulgaria · Пилокарпин Вижън
  • Cyprus · Prothenol
  • Germany · Pilocarpinhydrochlorid Bay Pharma, Pilocarpinhydrochlorid Smartpractice Europe
  • Spain · Colircusí, Pilocarpina Apotheke
  • Finland · Isopto Carpine, Salagen
  • France · Isopto, Pilocarpine Faure
  • United Kingdom (Northern Ireland) · Pilocarpine Hydrochloride, Pilocarpine Hydrochloride Blumont Pharma
  • Greece · Cidren, Dryboka
  • Hungary · Salagen
  • Ireland · Minims
  • Italy · Dropilton, Pilocarpina Farmigea
  • Luxembourg · Isopto, Spersacapin
  • Norway · Minims
  • Poland · Pilocarpinum Wzf
  • Portugal · Salagen
  • Sweden · Pilokarpin Karo Pharma, Salagen
  • Slovenia · Salagen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dfd634d1-0d77-43b0-a702-7041521155b3
GET /v1/drugs/dfd634d1-0d77-43b0-a702-7041521155b3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h21111_smpc.pdf",
  "strength": null,
  "atc_label": "Pilocarpine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg123101",
  "excipients": [
    "AMMONIA (E 527)",
    "CARNAUBAWAS (E 903)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE ZWART (E 172)",
    "MACROGOL 400",
    "POLYSORBAAT 80 (E 433)",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK GLAZE, GEDEELTELIJK VERESTERD",
    "STEARINEZUUR (E 570)",
    "TITAANDIOXIDE (E 171)",
    "ZWARTE INKT"
  ],
  "substances": [
    "PILOCARPINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h123101.pdf",
  "authorised_at": "2019/03/28",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "123101//21111",
  "additional_monitoring": "N"
}

See everything about pilocarpine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.